Adagene Inc. - Ordinary shares, par value US$0.0001 per share (ADAG)
CUSIP: 005329107
Q3 2021 13F Holders as of 30 Sep 2021
- Type / Class
- Equity / Ordinary shares, par value US$0.0001 per share
- Shares outstanding
- 46,844,314
- Total 13F shares
- 8,786,888
- Share change
- +2,848,957
- Total reported value
- $126,610,000
- Price per share
- $14.37
- Number of holders
- 19
- Value change
- +$41,051,156
- Number of buys
- 7
- Number of sells
- 8
Quarterly Holders Quick Answers
What is CUSIP 005329107?
CUSIP 005329107 identifies ADAG - Adagene Inc. - Ordinary shares, par value US$0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 005329107:
Top shareholders of ADAG - Adagene Inc. - Ordinary shares, par value US$0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| MORGAN STANLEY |
13F
|
Company |
3%
|
1,414,275
|
$19,178,000 | — | 30 Jun 2021 | |
| Artal Group S.A. |
13F
|
Company |
2.1%
|
1,000,000
|
$13,560,000 | — | 30 Jun 2021 | |
| Capital International Investors |
13F
|
Company |
2%
|
923,269
|
$12,520,000 | — | 30 Jun 2021 | |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.8%
|
838,500
|
$11,370,000 | — | 30 Jun 2021 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
0.71%
|
331,543
|
$4,496,000 | — | 30 Jun 2021 | |
| Capital International, Inc./CA/ |
13F
|
Company |
0.65%
|
304,876
|
$4,134,000 | — | 30 Jun 2021 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.59%
|
275,000
|
$3,729,000 | — | 30 Jun 2021 | |
| GENERAL ATLANTIC, L.P. |
13F
|
Individual |
0.56%
|
264,000
|
$3,580,000 | — | 30 Jun 2021 | |
| SUVRETTA CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.44%
|
204,000
|
$2,766,000 | — | 30 Jun 2021 | |
| Strategic Vision Investment Ltd |
13F
|
Company |
0.4%
|
189,700
|
$2,572,000 | — | 30 Jun 2021 | |
| Trellus Management Company, LLC |
13F
|
Company |
0.12%
|
55,000
|
$746,000 | — | 30 Jun 2021 | |
| TUDOR INVESTMENT CORP ET AL |
13F
|
Company |
0.1%
|
45,361
|
$615,000 | — | 30 Jun 2021 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.09%
|
40,000
|
$542,000 | — | 30 Jun 2021 | |
| Capital International Sarl |
13F
|
Company |
0.06%
|
28,392
|
$385,000 | — | 30 Jun 2021 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.05%
|
21,953
|
$298,000 | — | 30 Jun 2021 | |
| UBS Group AG |
13F
|
Company |
0%
|
2,062
|
$28,000 | — | 30 Jun 2021 |
Institutional Holders of Adagene Inc. - Ordinary shares, par value US$0.0001 per share (ADAG) as of Q3 2021
As of 30 Sep 2021,
Adagene Inc. - Ordinary shares, par value US$0.0001 per share (ADAG) was held by
19 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,786,888 shares.
The largest 10 holders included
MORGAN STANLEY, SC CHINA HOLDING Ltd, FMR LLC, Capital International Investors, Artal Group S.A., MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC, Hudson Bay Capital Management LP, CAPITAL INTERNATIONAL INC /CA/, CloudAlpha Capital Management Limited/Hong Kong, and ORBIMED ADVISORS LLC.
This page lists
19
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2021 vs Q2 2021 Across Filers
Q2 2021 holders
16
Q3 2021 holders
19
Holder diff
3
| Investor | Q2 2021 Shares | Q3 2021 Shares | Share Diff | Share Chg % | Q2 2021 Value $ | Q3 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.